In this episode of the American Amnion Association Podcast, host Theresa Hong speaks with David Pennington, a seasoned biotech executive, registered nurse, and pioneer in birth tissue innovation.
With a background that spans critical care, organ procurement, and leadership roles in tissue banks and regenerative medicine startups, David shares a powerful and personal perspective on the future of amnion-based medical products.
David discusses his early role in launching amniotic tissue applications in wound care, spine surgery, and ophthalmology, and the transformative results he’s witnessed throughout his career. From the science behind dry vs. cryopreserved amnion to innovations like topical ocular discs, this episode is packed with insider insight into what’s next for birth tissue-derived therapies.
Highlights Include:
✅ The early days of amnion in orthopedics, wound care, and eye care
✅ Clinical stories that show real patient impact
✅ Why amniotic tissue should be first-line therapy, not a last resort
✅ Challenges in FDA regulation and the hope for expanded access
✅ David’s vision for the next phase of regenerative medicine
Whether you’re in healthcare, biotech, or simply curious about birth tissue donation and its healing potential, this episode offers a compelling look into one of medicine’s most exciting frontiers.